New President & CEO Michel Lagarde Reports Initial Holdings in West Pharmaceutical Services ($WST)
WEST PHARMACEUTICAL SERVICES INC
Subscribe to track WST
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Form 3 Initial Ownership Filing: West Pharmaceutical Services Inc ($WST) Insider: Michel Lagarde (President and CEO, Director) Event Date: August 31, 2026 Direct Common Stock Holdings: 7,850 shares Derivative Securities: None reported
Comprehensive Analysis
Executive Summary
On September 10, 2026, West Pharmaceutical Services Inc ($WST) filed an initial statement of beneficial ownership (Form 3) for Michel Lagarde, reporting his position as President and CEO and Director effective August 31, 2026.
Reported Holdings
- Security: Common Stock
- Ownership Type: Direct (D)
- Shares Owned: 7,850 shares
- Derivative Holdings: None reported on Table II
Key Takeaways
This Form 3 filing establishes the initial baseline beneficial ownership for the newly appointed President and CEO, Michel Lagarde. Baseline disclosures represent initial status rather than new open-market purchase activity.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.